Best of the Blog: IN VIVO, April 2009
Executive Summary
A selection of our favorite blog posts from April 2009 for stories not covered elsewhere in this month's IN VIVO. (See them for free at http://invivoblog.blogspot.com/).
You may also be interested in...
Troubled Biotechs (UK Edition): Summit, Alizyme, ReNeuron
More than a third of UK biotechs are short of cash, and those that haven’t already found creative means of monetizing their assets have run out of time.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.